tiprankstipranks
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
US Market
Holding RLMD?
Track your performance easily

Relmada Therapeutics (RLMD) Technical Analysis

323 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Relmada Therapeutics’s (RLMD) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting Relmada Therapeutics is a Sell.
Relmada Therapeutics’s (RLMD) 20-Day exponential moving average is 0.45, while Relmada Therapeutics’s (RLMD) share price is $0.35, making it a Sell.
Relmada Therapeutics’s (RLMD) 50-Day exponential moving average is 1.01, while Relmada Therapeutics’s (RLMD) share price is $0.35, making it a Sell.

Relmada Therapeutics (RLMD) Pivot Points

Feb 01, 2025, 09:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.31
0.33
0.35
0.36
0.38
0.40
0.41
Fibonacci
0.33
0.34
0.35
0.36
0.38
0.38
0.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relmada Therapeutics (RLMD) Moving Averages

Feb 01, 2025, 09:37 PM
Period
Simple
Exponential
MA5
0.36Sell
0.36Sell
MA10
0.37Sell
0.37Sell
MA20
0.41Sell
0.45Sell
MA50
1.01Sell
1.01Sell
MA100
2.18Sell
1.78Sell
MA200
2.76Sell
2.68Sell
Relmada Therapeutics’s (RLMD) 10-Day exponential moving average is 0.37, while Relmada Therapeutics’s (RLMD) share price is $0.35, making it a Sell.
Relmada Therapeutics’s (RLMD) 100-Day exponential moving average is 1.78, while Relmada Therapeutics’s (RLMD) share price is $0.35, making it a Sell.
Relmada Therapeutics’s (RLMD) stock price is $0.35 and Relmada Therapeutics’s (RLMD) 50-day simple moving average is 1.01, creating a Sell signal.
Relmada Therapeutics’s (RLMD) stock price is $0.35 and Relmada Therapeutics’s (RLMD) 100-day simple moving average is 2.18, creating a Sell signal.
Relmada Therapeutics’s (RLMD) stock price is $0.35 and Relmada Therapeutics’s (RLMD) 200-day simple moving average is 2.76, creating a Sell signal.

Relmada Therapeutics (RLMD) Technical Indicators

Feb 01, 2025, 09:37 PM
Name
Value
Implied Action
RSI (14)
26.38
Buy
STOCH (9,6)
23.86
Neutral
STOCHRSI (14)
11.53
Buy
MACD (12,26)
-0.15
Sell
ADX (14)
42.73
Neutral
Williams %R
-92.04
Buy
CCI (14)
-99.28
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
44.20
Neutral
ROC
-22.22
Sell
Relmada Therapeutics’s (RLMD) Relative Strength Index (RSI) is 26.38, creating a Buy signal.
Relmada Therapeutics’s (RLMD) Trend Strength Indicator (ADX) is 42.73, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Commodity Channel Index (CCI) is -99.28, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Price Rate of Change (ROC) is -22.22, creating a Sell signal.

FAQ

Is RLMD a Buy, Hold, or Sell?
Based on RLMD’s technical indicators, RLMD is a Strong Sell.
    What is RLMD’s RSI (14)?
    RLMD’s RSI (14) is 26.38, which suggests RLMD is a Buy.
      What is RLMD’s MACD?
      RLMD’s MACD is -0.15, which suggests RLMD is a Sell.
        What is RLMD’s 5-day moving average?
        RLMD’s 5-day moving average is 0.36, which suggests RLMD is a Sell.
          What is RLMD’s 20-day moving average?
          RLMD 20-day moving average is 0.41, which suggests RLMD is a Sell.
            What is RLMD’s 50-day moving average?
            RLMD’s 50-day moving average is 1.01, which suggests RLMD is a Sell.
              What is RLMD’s 200-day moving average?
              RLMD’s 200-day moving average is 2.76, which suggests RLMD is a Sell.
                What is RLMD’s Williams % R (14)?
                RLMD’s Williams % R (14) is -92.04, which suggests RLMD is a Buy.
                  What is RLMD’s CCI (14)?
                  RLMD’s CCI (14) is -99.28, which suggests RLMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis